ARCHIVES

Clearinghouse Funds Two Carcinogens And A Threat To Humans

This article is from The Cancer Letter archive.

Vol. 04 No. 11 | March 17, 1978

Download PDF Visit The Full Archive

Related Articles

NCI Programs: 15 New Grants Awarded In Survivor Research

October 9, 1998

Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level

July 2, 1999

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

With NIH “Accountability” As Background, Advocates Support Budget Increases.

March 30, 2001